Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

ARS Pharmaceuticals (SPRY) Shares Issued: 2021-2025

Historic Shares Issued for ARS Pharmaceuticals (SPRY) over the last 4 years, with Sep 2025 value amounting to $479,000.

  • ARS Pharmaceuticals' Shares Issued fell 29.56% to $479,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year increase of 65.27%. This contributed to the annual value of $3.0 million for FY2024, which is 56.28% down from last year.
  • Per ARS Pharmaceuticals' latest filing, its Shares Issued stood at $479,000 for Q3 2025, which was down 82.24% from $2.7 million recorded in Q2 2025.
  • In the past 5 years, ARS Pharmaceuticals' Shares Issued ranged from a high of $2.9 million in Q2 2023 and a low of -$1.0 million during Q4 2021.
  • For the 3-year period, ARS Pharmaceuticals' Shares Issued averaged around $1.3 million, with its median value being $921,000 (2023).
  • In the last 5 years, ARS Pharmaceuticals' Shares Issued soared by 894.43% in 2023 and then slumped by 80.90% in 2024.
  • Quarterly analysis of 5 years shows ARS Pharmaceuticals' Shares Issued stood at -$1.0 million in 2021, then soared by 127.85% to $283,000 in 2022, then skyrocketed by 537.81% to $1.8 million in 2023, then decreased by 15.07% to $1.5 million in 2024, then dropped by 29.56% to $479,000 in 2025.
  • Its Shares Issued was $479,000 in Q3 2025, compared to $2.7 million in Q2 2025 and $725,000 in Q1 2025.